专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO1997021718A1 CRYSTALLINE 1-KESTOSE AND PROCESS FOR PREPARING THE SAME 审中-公开
标题翻译：晶体1-酮酶及其制备方法
公开(公告)号：WO1997021718A1
公开(公告)日：1997-06-19
申请号：PCT/JP1996003618
申请日：1996-12-11
申请人： MEIJI SEIKA KABUSHIKI KAISHA , NISHIZAWA, Koji , MATSUMOTO, Hitoshi , NAKAMURA, Hirofumi , KAWAKAMI, Takashi , NAKADA, Yuko , HIRAYAMA, Masao , ADACHI, Takashi
发明人： MEIJI SEIKA KABUSHIKI KAISHA
IPC分类号： C07H03/06
CPC分类号： C07H3/06 , C12P19/18 , C30B7/00
摘要： A process for preparing crystalline 1-kestose which enables crystalline 1-kestose in large fine granulated sugar form to be prepared with high recovery. The process comprises concentrating a high-purity 1-kestose solution to a Brix of not less than 75, depositing crystallites serving as a mother nucleus by adding seed crystals or by concentration under reduced pressure, and repeating at least twice the step of growing crystals by concentration under reduced pressure and the step of redissolving crystallites produced in the concentrate. Alternatively, the process comprises concentrating a high-purity 1-kestose solution to a Brix of not less than 80, growing crystals after addition of seed crystals or induction of crystallization, and repeating at least twice the step of lowering the temperature by 5 to 20 DEG C below the temperature in the previous step and the step of growing crystals growth by allowing the concentrate to stand at the above temperature. An enzyme capable of efficiently converting sucrose to 1-kestose is also disclosed.
摘要翻译：制备结晶1-kestose的方法，其使得能够以高回收率制备大细粒状糖形式的结晶1-kestose。该方法包括将高纯度1-kestose溶液浓缩至不小于75的白利糖度，通过加入晶种或通过减压浓缩沉积作为母核的微晶，并重复至少两次生长晶体的步骤在减压下的浓度和再浓缩浓缩物中产生的微晶的步骤。或者，该方法包括将高纯度1-kestose溶液浓缩至不低于80的白利糖度，加入晶种后生长晶体或诱导结晶，并重复至少两次将温度降低5至20的步骤 ℃以下，通过使浓缩物在上述温度下放置，生长晶体生长步骤。还公开了能够有效地将蔗糖转化成1-kestose的酶。

2. 发明申请

WO2008072484B1 DOOR OPEN/CLOSE SYSTEM FOR A VEHICLE 审中-公开
标题翻译：车辆的车门打开/关闭系统
公开(公告)号：WO2008072484B1
公开(公告)日：2008-08-14
申请号：PCT/JP2007073124
申请日：2007-11-22
申请人： YAZAKI CORP , TOYOTA AUTO BODY CO LTD , JITSUISHI NORIFUMI , MATSUMOTO HIRONORI , KAN TAKAHIRO , ADACHI TAKASHI , IMAIZUMI MOTOMU
发明人： JITSUISHI NORIFUMI , MATSUMOTO HIRONORI , KAN TAKAHIRO , ADACHI TAKASHI , IMAIZUMI MOTOMU
IPC分类号： E05B65/12
CPC分类号： E05B81/20 , Y10T292/1047 , Y10T292/1082
摘要： A door open/close system for a vehicle includes a plurality of door open/close devices 11, 11' having a latch mechanism 14 including a latch 13 for engaging with an engaging member 12, a motor 16a (16a1) for driving the latch mechanism 14, and a latch state detecting member 21 (211); and a control member 4 for starting to drive the motor of any one of all the door open/close device when the latch state detecting member of the one door open/close devices detects that the latch mechanism is in the half- latch state, said control member driving synchronously the motors of all the door open/close devices except the one door open/close device to change the latch mechanisms from the half-latch state to the full-latch state when the latch state detecting members o£all the door open/close devices except the one door open/close device k,; detect that the latch mechanisms are in the half-latch state in a case that the door of the vehicle is changed from a fully opened state to a fully closed state.
摘要翻译：用于车辆的车门开闭系统包括多个具有闩锁机构14的门开闭装置11,11'，该闩锁机构14包括用于与接合构件12接合的闩锁13，用于驱动闩锁机构的电动机16a（16a1） 14和闩锁状态检测部件21（211）; 以及控制部件4，当一个门开闭装置的闩锁状态检测部件检测到闩锁机构处于半锁定状态时，用于开始驱动全部门开闭装置中的任何一个的马达，所述控制部件同步地驱动除一个门开闭装置以外的所有门开闭装置的电动机，以在门锁状态检测部件在全门锁状态时将锁定机构从半锁定状态变为全锁定状态除了一个门打开/关闭装置k之外的打开/关闭装置; 在车辆的车门从全开状态变为全闭状态的情况下检测到闩锁机构处于半闩锁状态。

3. 发明申请

WO1998015196A1 COMPOSITIONS FOR POSTGASTRECTOMIC MINERAL SUPPLY 审中-公开
标题翻译：用于矿物质矿物质供应的组合物
公开(公告)号：WO1998015196A1
公开(公告)日：1998-04-16
申请号：PCT/JP1997003597
申请日：1997-10-08
申请人： MEIJI SEIKA KAISHA, LTD. , OHTSUKI, Masako , OHTA, Atsutane , TAKIZAWA, Toshio , ADACHI, Takashi
发明人： MEIJI SEIKA KAISHA, LTD.
IPC分类号： A23L01/304
CPC分类号： A61K47/26 , A23L33/16 , A61K33/00 , A61K33/06 , A61K33/08 , A61K33/10 , A61K33/26 , A61K33/42 , A61K2300/00
摘要： Compositions for supplying minerals to postgastrectomic patients to thereby treat or prevent postgastrectomic syndrome. These compositions contain hardly digestible oligosaccharides and/or hardly digestible sugar alcohols and minerals.
摘要翻译：用于向后胃镜检查患者提供矿物质的组合物，从而治疗或预防胃肠外综合征。这些组合物含有难消化的寡糖和/或难消化的糖醇和矿物质。

4. 发明申请

WO2008072484A1 DOOR OPEN/CLOSE SYSTEM FOR A VEHICLE 审中-公开
标题翻译：车门打开/关闭系统
公开(公告)号：WO2008072484A1
公开(公告)日：2008-06-19
申请号：PCT/JP2007/073124
申请日：2007-11-22
申请人： YAZAKI CORPORATION , TOYOTA AUTO BODY CO., LTD. , JITSUISHI, Norifumi , MATSUMOTO, Hironori , KAN, Takahiro , ADACHI, Takashi , IMAIZUMI, Motomu
发明人： JITSUISHI, Norifumi , MATSUMOTO, Hironori , KAN, Takahiro , ADACHI, Takashi , IMAIZUMI, Motomu
IPC分类号： E05B65/12
CPC分类号： E05B81/20 , Y10T292/1047 , Y10T292/1082
摘要： A door open/close system for a vehicle includes a plurality of door open/close devices 11, 11' having a latch mechanism 14 including a latch 13 for engaging with an engaging member 12, a motor 16a (16a1) for driving the latch mechanism 14, and a latch state detecting member 21 (211); and a control member 4 for starting to drive the motor of any one of all the door open/close device when the latch state detecting member of the one door open/close devices detects that the latch mechanism is in the half- latch state, said control member driving synchronously the motors of all the door open/close devices except the one door open/close device to change the latch mechanisms from the half-latch state to the full-latch state when the latch state detecting members o£all the door open/close devices except the one door open/close device k,; detect that the latch mechanisms are in the half-latch state in a case that the door of the vehicle is changed from a fully opened state to a fully closed state.
摘要翻译：用于车辆的门打开/关闭系统包括多个门打开/关闭装置11,11'，其具有闩锁机构14，该闩锁机构14包括用于与接合构件12接合的闩锁13;马达16a（16a1），用于驱动闩锁机构 14和闩锁状态检测构件21（211）; 以及控制部件4，当一个门打开/关闭装置的闩锁状态检测部件检测到闩锁机构处于半锁定状态时，开始驱动所有门打开/关闭装置中的任何一个的马达，所述控制部件4 控制构件同步地驱动除了一个门打开/关闭装置之外的所有门打开/关闭装置的电动机，以在闩锁状态检测构件全部门时将闩锁机构从半闩锁状态改变到完全闩锁状态打开/关闭装置除了一个门开/关装置k; 在车辆的门从完全打开状态变为完全关闭状态的情况下，检测到闩锁机构处于半闩锁状态。

5. 发明申请

WO1996010029A1 PROCESS FOR PRODUCING 12-HYDROXY-6-0-ALKYLERYTHROMYCIN AND ANALOGS THEREOF 审中-公开
标题翻译：生产12-羟基-6-0-甲基杀虫素及其类似物的方法
公开(公告)号：WO1996010029A1
公开(公告)日：1996-04-04
申请号：PCT/JP1995001908
申请日：1995-09-21
申请人： TAISHO PHARMACEUTICAL CO., LTD. , SASAKI, Joji , OHTA, Yoko , ADACHI, Takashi , MORIMOTO, Shigeo
发明人： TAISHO PHARMACEUTICAL CO., LTD.
IPC分类号： C07H17/08
CPC分类号： C12P19/62
摘要： Object: To provide a process for producing 12-hydroxy-6-0-methylerythromycin and analogs thereof in an easier manner. Constitution: A process for producing 12-hydroxy-6-O-alkylerythromycins and analogs thereof by adding a 6-O-alkylerythromycin having a hydrogen atom at the 12-position or an analog thereof to a solution containing the cells of an actinomyces that hydroxylates 6-O-alkylerythromyces and analogs thereof or an enzyme produced by the cells to convert the hydrogen atom to a hydroxyl group.
摘要翻译：目的：提供以更容易的方式生产12-羟基-6-0-甲基红霉素及其类似物的方法。构成：通过将12位具有氢原子的6-O-烷基红霉素或其类似物加入到含有羟基化的放线菌细胞的溶液中，生产12-羟基-6-O-烷基呋喃霉素及其类似物的方法 6-O-烷基红霉素及其类似物或由细胞产生的将氢原子转化为羟基的酶。

6. 发明申请

WO1994004701A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE 1,4-DIHYDROPYRIDINE COMPOUND 审中-公开
标题翻译：生产光学活性1,4-二氢吡啶化合物的方法
公开(公告)号：WO1994004701A1
公开(公告)日：1994-03-03
申请号：PCT/JP1992001074
申请日：1992-08-26
申请人： TAISHO PHARMACEUTICAL CO., LTD. , ADACHI, Takashi , IKEDA, Mayuma , HADACHI, Takako , HANADA, Kazunori
发明人： TAISHO PHARMACEUTICAL CO., LTD.
IPC分类号： C12P41/00
CPC分类号： C07D401/12 , C12P17/12 , C12P41/005
摘要： A process for producing an optically active 3-(2-nicotinoylaminoethyl)ester of (-)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid by asymmetrically hydrolyzing bis(2-nicotinoylaminoethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate or a salt thereof with an enzyme which can asymmetrically hydrolyze the carboxylate groups bonded to the 3- and 5-positions of a 1,4-dihydropyridine ring. The invention provides a process for producing a very important intermediate for producing only that optical isomer which is suitable as a medicine among the isomers of 3-(2-nicotinoylaminoethyl) 5-(3-nitroxypropyl) ester of 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid.
摘要翻译：（ - ） - 2,6-二甲基-4-（3-硝基苯基）-1,4-二氢吡啶-3,5-二羧酸的光学活性3-（2-烟酰氨基乙基）酯的不对称水解双（2-烟酰氨基乙基）2,6-二甲基-4-（3-硝基苯基）-1,4-二氢吡啶-3,5-二羧酸酯或其盐与可以不对称水解键合到3-和/ 1,4-二氢吡啶环的5位。本发明提供了一种生产非常重要的中间体的方法，该中间体仅用于制备适合作为药物的旋光异构体，该异构体是2,6-二甲基-4（3-甲氧基苯基）丙酸的3-（2-烟酰氨基乙基）-5-（3-硝基丙基）酯的异构体 - （3-硝基苯基）-1,4-二氢吡啶-3,5-二羧酸。

7. 发明申请

WO1994000576A1 VITAMIN D HYDROXYLASE GENE 审中-公开
标题翻译：维生素D羟基酶基因
公开(公告)号：WO1994000576A1
公开(公告)日：1994-01-06
申请号：PCT/JP1993000856
申请日：1993-06-24
申请人： TAISHO PHARMACEUTICAL CO., LTD. , KAWAUCHI, Hiroyuki , SASAKI, Joji , ADACHI, Takashi , HANADA, Kazunori , BEPPU, Teruhiko , HORINOUCHI, Sueharu
发明人： TAISHO PHARMACEUTICAL CO., LTD.
IPC分类号： C12N15/53
CPC分类号： C12N9/0073 , C12P7/02 , C12Y114/13013
摘要： A gene having the activity of a hydroxylase that can convert the hydrogen atom at the 25-position of a vitamin D into a hydroxyl group is obtained from the strain of an actinomyces of the genus (Nocardia) or (Amycolata). A 25-hydroxylated vitamin D can be prepared efficiently in a high yield by transforming (Streptomyces lividans) or (Streptomyces griseus) with a plasmid bearing the above gene and treating a vitamin D having a hydrogen atom at the 25-position with the resultant transformant.
摘要翻译：可以从属（诺卡氏菌属）（Amycolata）的放线菌的菌株获得具有可将维生素D的25位上的氢原子转化为羟基的羟化酶活性的基因。通过用带有上述基因的质粒转化（变链链霉菌）或（Streptomyces griseus）），可以高效率制备25-羟基化维生素D，并用所得转化体处理具有25位氢原子的维生素D 。

8. 发明申请

WO1996038157A1 INHIBITOR FOR LIPID PEROXIDE INCREASE 审中-公开
标题翻译：脂肪过氧化物增加抑制剂
公开(公告)号：WO1996038157A1
公开(公告)日：1996-12-05
申请号：PCT/JP1996001471
申请日：1996-05-30
申请人： MEIJI SEIKA KAISHA, LTD. , OHTA, Atsutane , OTSUKI, Masako , TAKIZAWA, Toshio , ADACHI, Takashi
发明人： MEIJI SEIKA KAISHA, LTD.
IPC分类号： A61K31/70
CPC分类号： A61K31/702 , A23L5/00 , A23L29/30
摘要： An inhibitor for lipid peroxide increase which comprises fructoligosaccharides whereby a food or drink having an excellent effect of inhibiting an increase in lipid peroxides without largely changing the daily diets can be provided at a low cost. Intake of the inhibitor can provide an excellent means for preventing various diseases caused by the formation of lipid peroxides (cancer, arteriosclerosis, etc.), retarding the aging process, etc.
摘要翻译：脂肪过氧化物增加的抑制剂，其包含果寡糖，从而可以以低成本提供具有抑制脂质过氧化物增加而没有大幅改变日粮的优异效果的食品或饮料。抑制剂的摄取可以提供防止脂质过氧化物（癌症，动脉硬化等）形成引起的各种疾病，延缓衰老过程等的极好手段。

9. 发明申请

WO1996010020A1 ISOBENZOFURANONE COMPOUND AND LIPID LOWERING AGENT 审中-公开
标题翻译： ISOBENZOFURANONE化合物和脂肪降解剂
公开(公告)号：WO1996010020A1
公开(公告)日：1996-04-04
申请号：PCT/JP1995001930
申请日：1995-09-25
申请人： TAISHO PHARMACEUTICAL CO., LTD. , SICHUAN INDUSTRIAL INSTITUTE OF ANTIBIOTIC OF STATE PHARMACEUTICAL ADMINISTRATION , ADACHI, Takashi , TAKAGI, Izumi , KONDO, Kazuyuki , KAWASHIMA, Akira , KOBAYASHI, Akio , TANEOKA, Ikuyo , MORIMOTO, Shigeo , HE, Bi, Mei , CHEN, Zengxiang
发明人： TAISHO PHARMACEUTICAL CO., LTD. , SICHUAN INDUSTRIAL INSTITUTE OF ANTIBIOTIC OF STATE PHARMACEUTICAL ADMINISTRATION
IPC分类号： C07D307/88
CPC分类号： C07D493/10 , C07D307/88
摘要： An isobenzofuranone compound represented by general formula (I) or a pharmaceutically acceptable salt thereof and a novel lipid lowering agent based on the effect of promoting the incorporation of LDL, wherein R represents C1-C5 alkoxy; R represents hydrogen, hydroxyl, C1-C18 alkoxy, C3-C6 cycloalkoxy, C2-C6 alkoxyalkoxy, C3-C7 alkoxyalkoxyalkoxy, C2-C6 alkylthioalkoxy, C7-C9 phenylalkoxy, C3-C5 alkenyloxy, C3-C5 alkynyloxy, C3-C6 alkanoyloxyalkoxy, C2-C6 alkanoyloxy, cyclic amine-substituted alkoxy, trifluoromethylsulfonyloxy, phenoxy or nitrophenoxy; and R represents (a), (b) or (c).
摘要翻译：由通式（I）表示的异苯并呋喃酮化合物或其药学上可接受的盐和基于促进LDL掺入的作用的新型降脂剂，其中R 1表示C1-C5烷氧基; R 2表示氢，羟基，C 1 -C 18烷氧基，C 3 -C 6环烷氧基，C 2 -C 6烷氧基烷氧基，C 3 -C 7烷氧基烷氧基烷氧基，C 2 -C 6烷硫基烷氧基，C 7 -C 9苯烷氧基，C 3 -C 5链烯氧基，C 3 -C 5炔氧基，C 3 -C 6烷酰氧基烷氧基，C 2 -C 6烷酰氧基，环胺取代的烷氧基，三氟甲基磺酰氧基，苯氧基或硝基苯氧基; R 3表示（a），（b）或（c）。

10. 发明申请

WO1995024909A1 OSTEOPOROSIS PREVENTING OR TREATING AGENT 审中-公开
标题翻译：防腐或治疗药物
公开(公告)号：WO1995024909A1
公开(公告)日：1995-09-21
申请号：PCT/JP1995000413
申请日：1995-03-13
申请人： MEIJI SEIKA KAISHA, LTD. , OHTA, Atsutane , TAKIZAWA, Toshio , ADACHI, Takashi
发明人： MEIJI SEIKA KAISHA, LTD.
IPC分类号： A61K33/06
CPC分类号： A61K33/42 , A61K33/06 , A61K33/26 , A61K31/70 , A61K31/715 , A61K2300/00
摘要： An osteoporosis preventing or treating agent containing minerals and difficultly digestible oligosaccharides, excellent in calcium absorption and capable of suppressing reduction in bone-salt content accompanying osteoporosis. Therefore it can effectively prevent the occurence or retard the progress of osteoporosis frequently met by postmenopausal women.
摘要翻译：一种骨质疏松症预防或治疗剂，其含有矿物质和难消化的寡糖，其钙吸收性优异，并且能够抑制随骨质疏松症引起的骨盐含量的降低。因此可有效预防绝经后女性经常遇到的骨质疏松症的发生或延缓。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式